- Home
- AX vs AXSM Comparison
AX vs AXSM Comparison
Compare AX & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AX
- AXSM
- Stock Information
- Founded
- AX 1999
- AXSM 2012
- Country
- AX United States
- AXSM United States
- Employees
- AX N/A
- AXSM N/A
- Industry
- AX Savings Institutions
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- AX Finance
- AXSM Health Care
- Exchange
- AX Nasdaq
- AXSM Nasdaq
- Market Cap
- AX 3.9B
- AXSM 4.0B
- IPO Year
- AX 2005
- AXSM 2015
- Fundamental
- Price
- AX $63.47
- AXSM $93.19
- Analyst Decision
- AX Buy
- AXSM Strong Buy
- Analyst Count
- AX 4
- AXSM 14
- Target Price
- AX $81.00
- AXSM $125.67
- AVG Volume (30 Days)
- AX 498.4K
- AXSM 427.1K
- Earning Date
- AX 10-24-2024
- AXSM 11-04-2024
- Dividend Yield
- AX N/A
- AXSM N/A
- EPS Growth
- AX 51.08
- AXSM N/A
- EPS
- AX 7.66
- AXSM N/A
- Revenue
- AX $1,059,192,000.00
- AXSM $291,489,000.00
- Revenue This Year
- AX N/A
- AXSM $42.50
- Revenue Next Year
- AX $7.96
- AXSM $69.28
- P/E Ratio
- AX $8.29
- AXSM N/A
- Revenue Growth
- AX 20.45
- AXSM 59.73
- 52 Week Low
- AX $32.05
- AXSM $55.02
- 52 Week High
- AX $79.15
- AXSM $98.40
- Technical
- Relative Strength Index (RSI)
- AX 41.30
- AXSM 64.50
- Support Level
- AX $67.47
- AXSM $88.04
- Resistance Level
- AX $69.87
- AXSM $97.00
- Average True Range (ATR)
- AX 2.02
- AXSM 3.03
- MACD
- AX -0.25
- AXSM 0.49
- Stochastic Oscillator
- AX 6.23
- AXSM 64.58
About AX Axos Financial Inc.
Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment . The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.